Drugs / bOPV 1,3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06920069 | May 2025 → Jul 2030 expected | poliomyelitis | Institute of Medical Biology, Chinese Academy of Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bOPV 1,3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06920069 ↗ |
| Modality | Vaccine | “Poliomyelitis Vaccine Type I Type Ⅲ in Dragee Candy (Human Diploid Cell), Live” NCT06920069 ↗ |